Belz M, Besse M, Krech L, Methfessel I, Zilles D
Klinik für Psychiatrie und Psychotherapie, Station 4193, Universitätsmedizin Göttingen, v. Siebold-Str. 3, 37075, Göttingen, Deutschland.
Nervenarzt. 2018 Nov;89(11):1271-1276. doi: 10.1007/s00115-018-0604-3.
Electroconvulsive therapy (ECT) is a highly effective, yet still controversial therapy for both the general public and psychiatrists. In this study, we investigated the patients’ view regarding effectiveness and tolerability of electroconvulsive therapy under consideration of individual clinical response.
In 31 patients with major depression, subjective effectiveness and tolerability were assessed via a differentiated questionnaire prior to, during, and after ECT. Symptoms were rated using the Montgomery-Åsberg depression rating scale (MADRS) and the Beck depression inventory II (BDI-II).
Patients assessed ECT to be generally effective both before and after the treatment. This view was independent of their individual treatment success. In contrast, patients’ rating of individual effectiveness depended on the objective improvement of their symptoms. Side effects were rated to be generally slight to moderate.
Against the background of persisting criticism towards ECT, the viewpoint of involved patients provides us with important references for an appropriate judgement of this therapy. The results suggest a good benefit-risk ratio for ECT from the patients’ perspective.
电休克疗法（ECT）对于普通大众和精神科医生而言，都是一种高效但仍具争议的治疗方法。在本研究中，我们在考虑个体临床反应的情况下，调查了患者对电休克疗法有效性和耐受性的看法。
对31例重度抑郁症患者，在ECT治疗前、治疗期间和治疗后，通过一份详细的问卷评估主观有效性和耐受性。使用蒙哥马利-奥斯伯格抑郁评定量表（MADRS）和贝克抑郁量表第二版（BDI-II）对症状进行评分。
患者在治疗前和治疗后均认为ECT总体有效。这一观点与他们个体的治疗效果无关。相比之下，患者对个体有效性的评分取决于其症状的客观改善情况。副作用总体被评为轻度至中度。
在对ECT持续存在批评的背景下，相关患者的观点为我们对这种治疗方法进行恰当判断提供了重要参考。结果表明，从患者角度来看，ECT的效益风险比良好。
